CN101690836A - Oxygen humidifying liquid - Google Patents
Oxygen humidifying liquid Download PDFInfo
- Publication number
- CN101690836A CN101690836A CN200910075708A CN200910075708A CN101690836A CN 101690836 A CN101690836 A CN 101690836A CN 200910075708 A CN200910075708 A CN 200910075708A CN 200910075708 A CN200910075708 A CN 200910075708A CN 101690836 A CN101690836 A CN 101690836A
- Authority
- CN
- China
- Prior art keywords
- humidifying liquid
- oxygen
- oxygen humidifying
- weight
- polylysine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The invention discloses an oxygen humidifying liquid which is applied to the medical field and is used in the process of oxygen therapy. The oxygen humidifying liquid mainly comprises epsilon-polylysine and water, and antibacterial agents can also be added. The oxygen humidifying liquid can effectively inhibit the propagation of bacteria and can ensure that the humidifying liquid can not be infected, thereby avoiding the occurrence of cross infection and further improving the comfort level of patients when inhaling oxygen and improving the working efficiency of nursing personnel.
Description
Technical field
The present invention relates to medical field, be meant a kind of oxygen humidifying liquid that is used for the moistening oxygen of oxygen uptake equipment especially.
Background technology
In medical field, oxygen therapy is the most frequently used clinically a kind of nursing technique and rescue means at present, and the oxygen of suction generally all can be handled through humidifying, makes and contains certain moisture in the oxygen.Oxygen humidifying liquid plays the effect of abundant humidifying to oxygen in process of oxygen therapy, avoided the stimulation of exsiccant oxygen to respiratory mucosa, improves patient's the comfort level and the effect of oxygen therapy.But use or other reason owing to intersecting, humidification fluid is sometimes by courses of infection, thereby the respiratory tract infection of the oxygen therapic patient that causes, the cross infection of Fa Shenging is to take place in the medical field to infect and the very important factor of complication thus, also is simultaneously the big obstacle that restriction improves the medical nursing work quality.Widely used clinically at present oxygen humidifying liquid is a distilled water, but because distilled water itself does not possess sterilization, bacteriostasis, very easily breeds antibacterial in a humid environment again, so be not ideal oxygen humidifying liquid.Therefore how to control the situation of carrying disease germs of oxygen humidifying liquid, the cross infection that reduces patient in the process of oxygen therapy has become the major issue of the concern of present medical field.
Summary of the invention
The present invention is for overcoming above shortcoming, provides a kind of and can effectively sterilize, antibacterial, improves the oxygen humidifying liquid of patients accepting oxygen inhalation comfort level.
For solving the problems of the technologies described above, the technical solution used in the present invention is:
A kind of oxygen humidifying liquid comprises water, also comprises epsilon-polylysine, and wherein the parts by weight of epsilon-polylysine and water are: epsilon-polylysine 0.01-0.5 part, 1000 parts in water.
Further improvement of the present invention is: comprise also in the described oxygen humidifying liquid that other antibacterial, antibacterial are the wherein a kind of of copper sulfate, sodium chloride, citric acid, glycine, acetic acid or ethanol.
The further concrete of technique scheme improved, and the parts by weight of the shared oxygen humidifying liquid of copper sulfate are 0.05-0.2 part.
As a further improvement on the present invention, the parts by weight of the shared oxygen humidifying liquid of sodium chloride are 0.1-1.5 part.
As a further improvement on the present invention, the parts by weight of the shared oxygen humidifying liquid of citric acid are 0.01-10 part.
As a further improvement on the present invention, the parts by weight of the shared oxygen humidifying liquid of glycine are 0.01-10 part.
As a further improvement on the present invention, the parts by weight of the shared oxygen humidifying liquid of acetic acid are 0.01-0.5 part.
As a further improvement on the present invention, the parts by weight of the shared oxygen humidifying liquid of ethanol are 0.2-5 part.
Owing to adopted above technical scheme, the invention technological progress is:
The hygroscopicity of epsilon-polylysine is strong, can decompose in human body, can be absorbed by the human body catapepsis, has tangible bacteriostasis, and without any toxic and side effects.Epsilon-polylysine is very good to the inhibition effect of gram negative bacteria, escherichia coli, Salmonella and most of G+, G-antibacterial, fungus, virus etc. especially, even when concentration is very low, also can play fungistatic effect, and be not subjected to the influence of pH value, the heat stability height, can together carry out sterilization treatment with solvent, be a kind of safe, efficient, reagent of having no side effect, it is respond well to be used for oxygen humidifying liquid; Epsilon-polylysine and acetic acid, citric acid share has the obvious suppression effect to Bacillus subtillis; Epsilon-polylysine share fungistatic effect than use is more obvious separately with glycine, copper sulfate, sodium chloride; Epsilon-polylysine and ethanol share also has the obvious suppression effect to budding fungus, and different antibacterial can be selected for use according to different crowds.Pathogenic bacterium and conditioned pathogen in the oxygen humidifying liquid can be killed or reduce to simple, cheap, easy preservation that the present invention disposes, and it is also less to change number of times, can play good sterilization, moistening purpose; Comfort level in the time of can improving patients accepting oxygen inhalation after the process humidifying simultaneously, and can improve the efficient of nursery work.
The specific embodiment
Below in conjunction with specific embodiment the present invention is described in more detail.
Following examples only limit to illustrate the present invention, do not limit the present invention.
Embodiment 1:
Embodiment 2: the embodiment that contains the copper sulfate composition.
Embodiment 3: the embodiment that contains the sodium chloride composition.
Embodiment 4: the embodiment that contains the citric acid composition.
Embodiment 5: the embodiment that contains the glycine composition.
Embodiment 6: the embodiment that contains acetate component.
Embodiment 7: the embodiment that contains alcoholic content.
Claims (8)
1. an oxygen humidifying liquid comprises water, it is characterized in that: also comprise epsilon-polylysine, the parts by weight of epsilon-polylysine and water are:
Epsilon-polylysine 0.01-0.5 part, 1000 parts in water.
2. oxygen humidifying liquid according to claim 1 is characterized in that: also comprise the wherein a kind of of antibacterial copper sulfate, sodium chloride, citric acid, glycine, acetic acid or ethanol in the oxygen humidifying liquid.
3. oxygen humidifying liquid according to claim 2 is characterized in that: the shared parts by weight of described copper sulfate are 0.05-0.2 part.
4. oxygen humidifying liquid according to claim 2 is characterized in that: the shared parts by weight of described sodium chloride are 0.1-1.5 part.
5. oxygen humidifying liquid according to claim 2 is characterized in that: the shared parts by weight of described citric acid are 0.01-10 part.
6. oxygen humidifying liquid according to claim 2 is characterized in that: the shared parts by weight of described glycine are 0.01-10 part.
7. oxygen humidifying liquid according to claim 2 is characterized in that: the shared parts by weight of described acetic acid are 0.01-0.5 part.
8. oxygen humidifying liquid according to claim 2 is characterized in that: the shared parts by weight of described ethanol are 0.2-5 part.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200910075708A CN101690836A (en) | 2009-10-15 | 2009-10-15 | Oxygen humidifying liquid |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200910075708A CN101690836A (en) | 2009-10-15 | 2009-10-15 | Oxygen humidifying liquid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101690836A true CN101690836A (en) | 2010-04-07 |
Family
ID=42079584
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN200910075708A Pending CN101690836A (en) | 2009-10-15 | 2009-10-15 | Oxygen humidifying liquid |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101690836A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102326546A (en) * | 2011-07-07 | 2012-01-25 | 郑州拜纳佛生物工程股份有限公司 | Leave-on bio-bacteriostat |
| CN102941034A (en) * | 2011-11-18 | 2013-02-27 | 曹青春 | Medical humidification liquid having bacteriostasis function |
| CN104472541A (en) * | 2014-12-10 | 2015-04-01 | 杭州美泰医疗器械有限公司 | Oxygen humidifying fluid bacteriostatic agent |
| CN111838176A (en) * | 2020-08-05 | 2020-10-30 | 江苏中新瑞光学材料有限公司 | Oxygen humidifying liquid bacteriostatic agent |
-
2009
- 2009-10-15 CN CN200910075708A patent/CN101690836A/en active Pending
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102326546A (en) * | 2011-07-07 | 2012-01-25 | 郑州拜纳佛生物工程股份有限公司 | Leave-on bio-bacteriostat |
| CN102941034A (en) * | 2011-11-18 | 2013-02-27 | 曹青春 | Medical humidification liquid having bacteriostasis function |
| CN104472541A (en) * | 2014-12-10 | 2015-04-01 | 杭州美泰医疗器械有限公司 | Oxygen humidifying fluid bacteriostatic agent |
| CN111838176A (en) * | 2020-08-05 | 2020-10-30 | 江苏中新瑞光学材料有限公司 | Oxygen humidifying liquid bacteriostatic agent |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102657611B (en) | Sodium pyruvate nasal spray and preparation method thereof | |
| Fondevila | Potential use of silver nanoparticles as an additive in animal feeding | |
| CN103120703A (en) | Care solution for cleaning nasal cavity and related composition | |
| CN106581148A (en) | Nasal irrigation care solution | |
| Bąkowski et al. | Silver and zinc nanoparticles in animal nutrition–a review | |
| CN100588455C (en) | Drying agent for absorbing ammonia | |
| CN101690836A (en) | Oxygen humidifying liquid | |
| CN102389743A (en) | Formula of medical bacteriostatic humidifying solution | |
| CN105498687B (en) | A kind of environment-friendly type livestock and poultry farm environmental improvement agent and preparation method and application | |
| CN103070881B (en) | A kind of vagina is antibacterial, virucidal compositions and application thereof | |
| CN112369430A (en) | Chlorine dioxide nano zinc disinfection and bacteriostasis solution | |
| CN103493850A (en) | Special air antiseptic for air cleaner | |
| RU2353376C1 (en) | Method of bronchial pneumonia treatment and prevention in calves and piglets | |
| CN102941034A (en) | Medical humidification liquid having bacteriostasis function | |
| CN103550806A (en) | Air refreshing agent with mosquito repelling effect | |
| CN106472560A (en) | A kind of oxygen humidifying liquid bacteriostatic agent | |
| CN201862088U (en) | Medical sterilizing atomizer | |
| CN105709140A (en) | Medicine composition for treating hypersensitivity pneumonitis and preparation method thereof | |
| CN103908479A (en) | Medical hydrogel for treating gynecological diseases or skin diseases and application of medical hydrogel | |
| CN109833331A (en) | A kind of preparation and preparation method thereof for killing mycoplasma hyopneumoniae | |
| CN104472541A (en) | Oxygen humidifying fluid bacteriostatic agent | |
| CN104041960A (en) | Antivirus medicine treatment mask | |
| CN103719167A (en) | Degerming agent specially used for aeromonas hydrophila water body | |
| CN103655612A (en) | Treatment method of channel catfish apiosomasis of eel | |
| CN105412379A (en) | Inhalation-type phthisis treatment preparation and preparing method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20100407 |